Tuesday, 02 January 2024 12:17 GMT

Oncolytics Biotech Inc


(MENAFN- Baystreet) 10:02 AM EST - Oncolytics Biotech Inc: Announced it has filed a registration statement on Form F-4 with the Securities and Exchange Commission that includes a preliminary management circular/prospectus and other relevant documents related to various proposals contained therein, and has plans to hold a Special Meeting of Shareholders to vote on, among other things, a series of transactions that will change the jurisdiction of Oncolytics from the Province of Alberta in Canada to the State of Nevada in the United States of America. Oncolytics Biotech Inc shares N are trading -$0.03 at $1.15.

Full Press Release:

MENAFN20102025000212011056ID1110221084



Baystreet.ca

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.